Our role is to carefully screen each patient and help them choose the solution that best matches their lifestyle.”— Dr.

Science Corp. raised $230 million as it awaits a decision from the FDA on PRIMA, their wireless retinal implant.

Science has added a whole lot more cash to the bank, bringing in an impressive $230 million in its latest raise. | Science has added a whole lot more cash to the bank, bringing in an impressive $230 ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious medical conditions, ...